Cargando…
P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430905/ http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b |
_version_ | 1785091071565365248 |
---|---|
author | Guo, Yuelu Hu, Kai Ke, Xiaoyan Xu, Teng Feng, Shaomei Zheng, Peihao MA, Lixia Yang, Fan Shi, Hui Deng, Biping Rui, Liu Fu, Zhonghua |
author_facet | Guo, Yuelu Hu, Kai Ke, Xiaoyan Xu, Teng Feng, Shaomei Zheng, Peihao MA, Lixia Yang, Fan Shi, Hui Deng, Biping Rui, Liu Fu, Zhonghua |
author_sort | Guo, Yuelu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104309052023-08-17 P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. Guo, Yuelu Hu, Kai Ke, Xiaoyan Xu, Teng Feng, Shaomei Zheng, Peihao MA, Lixia Yang, Fan Shi, Hui Deng, Biping Rui, Liu Fu, Zhonghua Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430905/ http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Guo, Yuelu Hu, Kai Ke, Xiaoyan Xu, Teng Feng, Shaomei Zheng, Peihao MA, Lixia Yang, Fan Shi, Hui Deng, Biping Rui, Liu Fu, Zhonghua P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title_full | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title_fullStr | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title_full_unstemmed | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title_short | P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA. |
title_sort | p1195: a prospective study of targeted sequential immunotherapy. in patients with relapsed refractory primary mediastinal large b-cell lymphoma. |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430905/ http://dx.doi.org/10.1097/01.HS9.0000971676.94450.1b |
work_keys_str_mv | AT guoyuelu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT hukai p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT kexiaoyan p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT xuteng p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT fengshaomei p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT zhengpeihao p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT malixia p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT yangfan p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT shihui p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT dengbiping p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT ruiliu p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma AT fuzhonghua p1195aprospectivestudyoftargetedsequentialimmunotherapyinpatientswithrelapsedrefractoryprimarymediastinallargebcelllymphoma |